乳腺癌中的瘤芽:系统性审查和元分析
Archana Buch1, Uzair Khan2, Hetal Rathod3
1Department of Pathology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
Journal of cancer research and therapeutics
|February 20, 2024
概括
瘤芽,癌细胞入侵的标志物,是乳腺癌的显著预后因素. 这一元分析证实了它与诸如淋巴结转移和淋巴血管入侵等侵略性特征的关联.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 癌症研究 癌症研究
背景情况:
- 瘤芽越来越被认为是癌症的预后指标,与上皮-介质细胞过渡 (EMT) 和患者的治疗结果有关.
- 乳腺癌中瘤芽的标准报告缺乏,需要进行全面的审查.
- 这项研究旨在通过系统的文献审查和元分析来评估乳腺癌中瘤芽的预后意义.
结论:
- 尽管异质,瘤芽显示出作为乳腺癌的独立预后标志物的潜力.
- 瘤芽评估的标准化对于一致的临床应用至关重要.
- 需要进一步的研究来完善分级系统并验证其预后价值.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346


